CMPI Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer...

Stats
Today's Volume	63 651.00
Average Volume	233 019
Market Cap	0.00
EPS	$-0.730 ( 2022-05-12 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.85
ATR14	$0.291 (2.77%)

Insider Trading

Date	Person	Action	Amount	type
2022-05-31	Powell Michael	Sell	30 000	Stock Option (Right to Buy)
2022-05-31	Powell Michael	Sell	10 030	Stock Option (Right to Buy)
2022-05-31	Powell Michael	Sell	30 000	Stock Option (Right to Buy)
2022-05-31	Flaherty Keith T.	Sell	10 030	Stock Option (Right to Buy)
2022-05-31	Flaherty Keith T.	Sell	4 012	Stock Option (Right to Buy)

INSIDER POWER
-100.00
Last 90 transactions
Buy: 10 162 192 \| Sell: 69 692 426

Volume Correlation

Long: 0.41 (neutral)

Short: -0.45 (neutral)

Signal:(88.816) Neutral

Checkmate Correlation

10 Most Positive Correlations
WPRT	0.988
APTO	0.981
ORTX	0.973
RESN	0.969
RXDX	0.969
ZGNX	0.965
ACOR	0.965
IMGN	0.963
PBPB	0.961
GNLN	0.961

10 Most Negative Correlations
EYE	-0.966
IEP	-0.958
PEBK	-0.956
PINC	-0.955
AADI	-0.951
CMLS	-0.95
CPTN	-0.949
MDRX	-0.949
ALHC	-0.946
LCUT	-0.945

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Checkmate Correlation - Currency/Commodity

-0.46
( neutral )

0.24
( neutral )

0.07
( neutral )

0.06
( neutral )

0.71
( moderate )

Checkmate Financials

Annual	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-6.42

Q1	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.730

Q4	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.617

Q3	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.690

Financial Reports:

No articles found.

Checkmate

Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant melanoma; and treatment in patients with PD-1 refractory melanoma. Checkmate Pharmaceuticals, Inc. has strategic alliances with Merck KGaA and Pfizer. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. As of May 27, 2022, Checkmate Pharmaceuticals, Inc. operates as a subsidiary of Regeneron Pharmaceuticals, Inc.